Amy Paller, MD
@pallerlab.bsky.social
With the possibility that measles is on the rise, we dermatologists need to be on the lookout for children or adults coming in with the measles morbilliform rash and a history (high fever,cold symptoms,eye redness) that is suspicious for this highly contagious disease
www.healio.com/news/dermato...
www.healio.com/news/dermato...
Beneath the Surface: How to recognize and diagnose measles
Measles, which was declared to be eliminated in 2000 in the United States, has seen a resurgence, with more than 2,000 cases documented in 2025.This is the highest number of cases since elimination wa...
www.healio.com
January 21, 2026 at 3:42 AM
With the possibility that measles is on the rise, we dermatologists need to be on the lookout for children or adults coming in with the measles morbilliform rash and a history (high fever,cold symptoms,eye redness) that is suspicious for this highly contagious disease
www.healio.com/news/dermato...
www.healio.com/news/dermato...
Reposted by Amy Paller, MD
Exciting opportunity in the Peng Lab at Northwestern, focusing on stem cells, autophagy, and epithelial biology. Please share with interested candidates!
postdocs.northwestern.edu/announcement...
#jobSky #postdocSky #dermSky #eyeSky
postdocs.northwestern.edu/announcement...
#jobSky #postdocSky #dermSky #eyeSky
December 19, 2025 at 2:42 AM
Exciting opportunity in the Peng Lab at Northwestern, focusing on stem cells, autophagy, and epithelial biology. Please share with interested candidates!
postdocs.northwestern.edu/announcement...
#jobSky #postdocSky #dermSky #eyeSky
postdocs.northwestern.edu/announcement...
#jobSky #postdocSky #dermSky #eyeSky
Excited that 3 organizations supporting Epidermal Differentiation Disorders are teaming to sponsor a special pre-SID program in Chicago that will include experts and patients. Hope to see you there.
www.pachyonychia.org/2026-edd-sym...
#DermSky #MedSky #raredisease #EDDs
www.pachyonychia.org/2026-edd-sym...
#DermSky #MedSky #raredisease #EDDs
December 16, 2025 at 4:35 AM
Excited that 3 organizations supporting Epidermal Differentiation Disorders are teaming to sponsor a special pre-SID program in Chicago that will include experts and patients. Hope to see you there.
www.pachyonychia.org/2026-edd-sym...
#DermSky #MedSky #raredisease #EDDs
www.pachyonychia.org/2026-edd-sym...
#DermSky #MedSky #raredisease #EDDs
We’re excited to see our Ichthyosis community come together again!
📅 Saturday, January 17, 2026
📍 Lurie Children’s Hospital, Chicago
It’s a special chance to meet others living with Ichthyosis, hear updates on ongoing research, and enjoy some fun and support together.
We hope to see you there 💙
📅 Saturday, January 17, 2026
📍 Lurie Children’s Hospital, Chicago
It’s a special chance to meet others living with Ichthyosis, hear updates on ongoing research, and enjoy some fun and support together.
We hope to see you there 💙
October 12, 2025 at 4:09 AM
We’re excited to see our Ichthyosis community come together again!
📅 Saturday, January 17, 2026
📍 Lurie Children’s Hospital, Chicago
It’s a special chance to meet others living with Ichthyosis, hear updates on ongoing research, and enjoy some fun and support together.
We hope to see you there 💙
📅 Saturday, January 17, 2026
📍 Lurie Children’s Hospital, Chicago
It’s a special chance to meet others living with Ichthyosis, hear updates on ongoing research, and enjoy some fun and support together.
We hope to see you there 💙
An Acid-Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa Wounds
#raredisease #epdermolysisbullosa #microbiome #dermsky #medsky
pubmed.ncbi.nlm.nih.gov/40803690/
#raredisease #epdermolysisbullosa #microbiome #dermsky #medsky
pubmed.ncbi.nlm.nih.gov/40803690/
August 14, 2025 at 1:00 PM
An Acid-Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa Wounds
#raredisease #epdermolysisbullosa #microbiome #dermsky #medsky
pubmed.ncbi.nlm.nih.gov/40803690/
#raredisease #epdermolysisbullosa #microbiome #dermsky #medsky
pubmed.ncbi.nlm.nih.gov/40803690/
New review article!
Deciding Which Patients With Atopic Dermatitis to Prioritize for Biologics and Janus Kinase Inhibitors
doi.org/10.1016/j.ja...
#dermsky #medsky
Deciding Which Patients With Atopic Dermatitis to Prioritize for Biologics and Janus Kinase Inhibitors
doi.org/10.1016/j.ja...
#dermsky #medsky
August 10, 2025 at 2:50 PM
New review article!
Deciding Which Patients With Atopic Dermatitis to Prioritize for Biologics and Janus Kinase Inhibitors
doi.org/10.1016/j.ja...
#dermsky #medsky
Deciding Which Patients With Atopic Dermatitis to Prioritize for Biologics and Janus Kinase Inhibitors
doi.org/10.1016/j.ja...
#dermsky #medsky
New Treatments in Atopic Dermatitis Update
#DermSky #MedSky
@annalsacaai.bsky.social
pubmed.ncbi.nlm.nih.gov/40562170/
#DermSky #MedSky
@annalsacaai.bsky.social
pubmed.ncbi.nlm.nih.gov/40562170/
June 27, 2025 at 3:44 AM
New Treatments in Atopic Dermatitis Update
#DermSky #MedSky
@annalsacaai.bsky.social
pubmed.ncbi.nlm.nih.gov/40562170/
#DermSky #MedSky
@annalsacaai.bsky.social
pubmed.ncbi.nlm.nih.gov/40562170/
Excited to share that three of our lab members are presenting their work at # #SIDSanDiego25! Come support them at their talks and poster sessions.
@siderm.bsky.social
#DermSky
@siderm.bsky.social
#DermSky
May 6, 2025 at 2:55 PM
Excited to share that three of our lab members are presenting their work at # #SIDSanDiego25! Come support them at their talks and poster sessions.
@siderm.bsky.social
#DermSky
@siderm.bsky.social
#DermSky
Having a device that can measure TEWL remotely, continuously or as programmed by the investigator - and without perturbing a patient during sleep - is a major advance.
#wearabledevices #DermSky
A non-contact wearable device for monitoring epidermal molecular flux
www.nature.com/articles/s41...
#wearabledevices #DermSky
A non-contact wearable device for monitoring epidermal molecular flux
www.nature.com/articles/s41...
April 11, 2025 at 1:12 PM
Having a device that can measure TEWL remotely, continuously or as programmed by the investigator - and without perturbing a patient during sleep - is a major advance.
#wearabledevices #DermSky
A non-contact wearable device for monitoring epidermal molecular flux
www.nature.com/articles/s41...
#wearabledevices #DermSky
A non-contact wearable device for monitoring epidermal molecular flux
www.nature.com/articles/s41...
A new classification of hereditary EDDs highlights shared disease mechanisms—unlocking targeted, pathogenesis-based treatments. From lovastatin-cholesterol to kallikrein inhibitors and gene editing, care for syndromic ichthyosis is evolving.
doi.org/10.1093/bjd/...
#raredisease #MedSky #DermSky
doi.org/10.1093/bjd/...
#raredisease #MedSky #DermSky
April 5, 2025 at 3:47 PM
A new classification of hereditary EDDs highlights shared disease mechanisms—unlocking targeted, pathogenesis-based treatments. From lovastatin-cholesterol to kallikrein inhibitors and gene editing, care for syndromic ichthyosis is evolving.
doi.org/10.1093/bjd/...
#raredisease #MedSky #DermSky
doi.org/10.1093/bjd/...
#raredisease #MedSky #DermSky
Long-term dupilumab treatment in young children (6mo–5y) with moderate-to-severe AD shows low infection rates. This reinforces its strong safety profile for pediatric eczema care.
#AtopicDermatitis #Dupilumab #PediatricDermatology #medsky #dermsky
Read more: eprints.whiterose.ac.uk/220380/
#AtopicDermatitis #Dupilumab #PediatricDermatology #medsky #dermsky
Read more: eprints.whiterose.ac.uk/220380/
March 28, 2025 at 5:10 PM
Long-term dupilumab treatment in young children (6mo–5y) with moderate-to-severe AD shows low infection rates. This reinforces its strong safety profile for pediatric eczema care.
#AtopicDermatitis #Dupilumab #PediatricDermatology #medsky #dermsky
Read more: eprints.whiterose.ac.uk/220380/
#AtopicDermatitis #Dupilumab #PediatricDermatology #medsky #dermsky
Read more: eprints.whiterose.ac.uk/220380/
New study on tapinarof cream 1% in pediatric AD! Minimal systemic absorption, favorable safety, and good tolerability in children (2–17 yrs)with extensive AD. The treatment was well tolerated, even on sensitive skin and flexural areas, with only mild folliculitis reported. #atopicdermatitis #dermsky
March 25, 2025 at 9:19 PM
New study on tapinarof cream 1% in pediatric AD! Minimal systemic absorption, favorable safety, and good tolerability in children (2–17 yrs)with extensive AD. The treatment was well tolerated, even on sensitive skin and flexural areas, with only mild folliculitis reported. #atopicdermatitis #dermsky
Great to be at #AAD2025, sharing our lab’s work and connecting with colleagues in the field. Exciting discussions and a fantastic meeting!
Science drives innovation, informs policy, and improves lives—let’s continue to champion its role in society.
#StandUpForScience
@aadmember.bsky.social
Science drives innovation, informs policy, and improves lives—let’s continue to champion its role in society.
#StandUpForScience
@aadmember.bsky.social
March 9, 2025 at 6:55 PM
Great to be at #AAD2025, sharing our lab’s work and connecting with colleagues in the field. Exciting discussions and a fantastic meeting!
Science drives innovation, informs policy, and improves lives—let’s continue to champion its role in society.
#StandUpForScience
@aadmember.bsky.social
Science drives innovation, informs policy, and improves lives—let’s continue to champion its role in society.
#StandUpForScience
@aadmember.bsky.social
Reposted by Amy Paller, MD
Debra and @charitydebra.bsky.social are delighted to support a clinical trial led by @pallerlab.bsky.social @nufeinbergmed.bsky.social.
The trial explores #repurposing Dupilumab - used for eczema - to treat itch, blistering, and pain in all types of #EB.
Read more 👉 bit.ly/Dupilumabtot...
The trial explores #repurposing Dupilumab - used for eczema - to treat itch, blistering, and pain in all types of #EB.
Read more 👉 bit.ly/Dupilumabtot...
February 25, 2025 at 2:26 PM
Debra and @charitydebra.bsky.social are delighted to support a clinical trial led by @pallerlab.bsky.social @nufeinbergmed.bsky.social.
The trial explores #repurposing Dupilumab - used for eczema - to treat itch, blistering, and pain in all types of #EB.
Read more 👉 bit.ly/Dupilumabtot...
The trial explores #repurposing Dupilumab - used for eczema - to treat itch, blistering, and pain in all types of #EB.
Read more 👉 bit.ly/Dupilumabtot...
Great to see some action in addressing the curtailing of science
#MedSky #DermSky #ScienceSky #StandUpForScience2025
#MedSky #DermSky #ScienceSky #StandUpForScience2025
Welcome to the Bluesky account for Stand Up for Science 2025!
Keep an eye on this space for updates, event information, and ways to get involved. We can't wait to see everyone #standupforscience2025 on March 7th, both in DC and locations nationwide!
#scienceforall #sciencenotsilence
Keep an eye on this space for updates, event information, and ways to get involved. We can't wait to see everyone #standupforscience2025 on March 7th, both in DC and locations nationwide!
#scienceforall #sciencenotsilence
February 15, 2025 at 8:23 PM
Great to see some action in addressing the curtailing of science
#MedSky #DermSky #ScienceSky #StandUpForScience2025
#MedSky #DermSky #ScienceSky #StandUpForScience2025
Excited about a device that both measures scratch based on finger movement and the sound of itch — and can optionally provide a haptic vibration when sensing scratch to stop it, even at night.
pubmed.ncbi.nlm.nih.gov/39908036/
pubmed.ncbi.nlm.nih.gov/39908036/
February 8, 2025 at 4:03 AM
Excited about a device that both measures scratch based on finger movement and the sound of itch — and can optionally provide a haptic vibration when sensing scratch to stop it, even at night.
pubmed.ncbi.nlm.nih.gov/39908036/
pubmed.ncbi.nlm.nih.gov/39908036/
ISPD Webinar on Neonatal dermatology
Saturday, 15 February
8 AM Eastern Standard Time (EST)
London: 1 PM | Dubai: 5 PM | Perth: 9 PM
Register:
www.ispedderm.com/webinar-1-ne...
Saturday, 15 February
8 AM Eastern Standard Time (EST)
London: 1 PM | Dubai: 5 PM | Perth: 9 PM
Register:
www.ispedderm.com/webinar-1-ne...
January 28, 2025 at 11:23 PM
ISPD Webinar on Neonatal dermatology
Saturday, 15 February
8 AM Eastern Standard Time (EST)
London: 1 PM | Dubai: 5 PM | Perth: 9 PM
Register:
www.ispedderm.com/webinar-1-ne...
Saturday, 15 February
8 AM Eastern Standard Time (EST)
London: 1 PM | Dubai: 5 PM | Perth: 9 PM
Register:
www.ispedderm.com/webinar-1-ne...
Biologics in congenital ichthyosis: are they effective?
doi: 10.1093/bjd/ljae420
pubmed.ncbi.nlm.nih.gov/39470394/
"Biologics may lead to improvement in only a subset of patients with congenital ichthyoses with only some of them noting a good response."
doi: 10.1093/bjd/ljae420
pubmed.ncbi.nlm.nih.gov/39470394/
"Biologics may lead to improvement in only a subset of patients with congenital ichthyoses with only some of them noting a good response."
January 26, 2025 at 8:02 PM
Biologics in congenital ichthyosis: are they effective?
doi: 10.1093/bjd/ljae420
pubmed.ncbi.nlm.nih.gov/39470394/
"Biologics may lead to improvement in only a subset of patients with congenital ichthyoses with only some of them noting a good response."
doi: 10.1093/bjd/ljae420
pubmed.ncbi.nlm.nih.gov/39470394/
"Biologics may lead to improvement in only a subset of patients with congenital ichthyoses with only some of them noting a good response."
Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis in the TARGET-DERM AD Registry
pubmed.ncbi.nlm.nih.gov/39623757/
#atopicdermatitis #dermatology
pubmed.ncbi.nlm.nih.gov/39623757/
#atopicdermatitis #dermatology
December 3, 2024 at 7:48 PM
Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis in the TARGET-DERM AD Registry
pubmed.ncbi.nlm.nih.gov/39623757/
#atopicdermatitis #dermatology
pubmed.ncbi.nlm.nih.gov/39623757/
#atopicdermatitis #dermatology
